Journals / Türkiye Diyabet ve Obezite Dergisi / 2021 / Cilt: 5 - Sayı: 1

The Importance of New Anthropometric Measurements in Detecting Cardio Metabolic Risk and Insulin Resistance in Patients with Polycystic Ovary Syndrome: Single Center Experience

Polikistik Over Sendromlu Hastalarda Yeni Antropometrik Ölçümlerin Kardiyometabolik Risk ve İnsülin Rezistansını Belirlemedeki Önemi

Pages
25–32
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The predictors of abdominal obesity as waist circumference, LAP, BAI, BRI, VAI, AVI, WHtR were significantly higher in patient with PCOS (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Abdominal obesity is frequently seen in Polycystic Ovary Syndrome (PCOS).
📊
Key Findings & Data:Methods: We included 62 patients with PCOS and 38 healthy individuals as control.
💡
Conclusion & Impact:Results: The predictors of abdominal obesity as waist circumference, LAP, BAI, BRI, VAI, AVI, WHtR were significantly higher in patient with PCOS (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Polikistik Over Sendromu · Ateroskleroz · Antropometri

Abstract

Objective: Abdominal obesity is frequently seen in Polycystic Ovary Syndrome (PCOS). The evaluation of abdominal obesity might be important according to metabolic and cardiovascular dysfunctions in patients with PCOS. We aimed to evaluate the new anthropometric measurements in patients with polycystic ovary syndrome (PCOS) and their relationship with cardiovascular risk and insulin resistance. Methods: We included 62 patients with PCOS and 38 healthy individuals as control. The clinical examinations, serum hormone levels and ultrasonographic findings of overs were evaluated. Anthropometric Measurements, HOMA-IR values and Carotid intima-media thickness (CIMT) measurements were evaluated. Results: The predictors of abdominal obesity as waist circumference, LAP, BAI, BRI, VAI, AVI, WHtR were significantly higher in patient with PCOS (p

Özet

Amaç: Polikistik Over Sendromunda (PKOS) abdominal obezite sıklıkla görülmektedir. Abdominal obezitenin değerlendirilmesi PKOS’lu hastalarda metabolik ve kardiyovasküler disfonksiyon açısından önemlidir. Bu çalışmada PKOS’lu hastalarda yeni antropometrik ölçümleri ve kardiyovasküler risk ve insülin rezistansı ile ilişkisini araştırmayı amaçladık. Gereç ve Yöntemler: Çalışmaya 62 PKOS’lu hasta ve 38 sağlıklı kontrol dahil edildi. Hastaların klinik bulguları, serum hormon düzeyleri ve overlerin ultrasonik bulguları değerlendirildi. Antropometrik ölçümler, HOMA-IR düzeyleri ve karotis intima media kalınlıkları (KIMK) değerlendirildi. Bulgular: Abdominal obezite belirteci olan bel çevresi, LAP, BAI, BRI, VAI, AVI ve WHtR PKOS’lu hastalarda anlamlı olarak yüksekti (p

🔖

Cite This Article

GÖNÜLALAN, G., SAÇKAN, F. (2022). The Importance of New Anthropometric Measurements in Detecting Cardio Metabolic Risk and Insulin Resistance in Patients with Polycystic Ovary Syndrome: Single Center Experience. Türkiye Diyabet ve Obezite Dergisi, Cilt: 5 - Sayı: 1, 25–32. https://ajindex.com/articles/627873

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Salehi M, Bravo-Vera R, Sheikh A, Gouller A, Poretsky L. Obesity in polycystic ovary syndrome: Two disease or one? Turk JEM. 2003;4:149-157
  2. Legro RS. Polycystic ovary syndrome and cardiovascular disease: A premature association? Endocr Rev. 2003;24:302- 312
  3. Lemieux S, Prud’homme D, Nadeau A, Tremblay A, Bouchard C, Despres JP. Seven-year changes in body fat and visceral adipose tissue in women. Association with indexes of plasma glucose-insulin homeostasis. Diabetes Care. 1996;19:983-991
  4. Dos Santos RE, Aldrighi JM, Lanz JR, Ferezin PC, Marone MMS. Relationship of body fat distribution by waist circumference, dual- energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and nonobese postmenopausal women. Gynecol Endocrinol. 2005;21:295-301
  5. Uruska A, Zozulinska-Ziolkiewicz D, Niedzwiecki P, Pietrzak M, Wierusz-Wysocka B. TG/HDL-C ratio and visceral adiposity index may be useful in assessment of insulin resistance in adults with type I diabetes in clinical practice. J Clin Lipidol. 2018;12:734-740
  6. Feng J, He S, Chen X. Body adiposity indexand body roundness index in identifying insulin resistance among adults without diabetes. Am J Med Sci. 2019;357:116-123
  7. Chen S, Chen Y, Liu X, Li M, Wu B, Li Y, Liang Y, Shao X, Holthöfer H, Zou H. Insulin resistance and metabolic syndrome in normal-weight individuals. Endocrine. 2014;46:496-504
  8. Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes: A population-based comparison. Diabetes Care. 2006;29:151-153
  9. Kahn HS. The lipid accumulation product performs better than the body mass index for recognizing cardiovascular risk: A population-based comparison. BMC Cardiovasc Disord. 2005;5:26
  10. Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19-25
  11. Tsigos C, Hainer V, Basdevant A, Finer N, Fried M, Mathus- Vliegen E, Micic D, Maislos M, Roman G, Schutz Y, Toplak H, Zahorska-Markiewicz B, Obesity Management Task Force of the European Association for the Study of Obesity. Management of obesity in adults: European clinical practice guidelines. Obesity Facts. 2008;1:106-116
  12. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A, AlkaMeSy Study Group. Visceral Adiposity Index: a reliable indicator of visceral fat fun